Non-Opioid Pain Patches Market to Reach $3.3 Billion by 2035

Non-opioid pain patches market was valued at $1.7 billion in 2025 and is projected to reach $3.3 billion by 2035, expanding at a CAGR of 6.5% during the forecast period. Rising prevalence of musculoskeletal disorders, increasing preference for non-opioid pain management therapies, and growing demand for transdermal drug delivery systems are contributing significantly to market expansion. According to the World Health Organization (WHO), nearly 1.71 billion people worldwide are living with musculoskeletal conditions, making them the leading contributor to disability globally. WHO further states that low back pain alone affects nearly 570 million people worldwide and remains the leading cause of disability across 160 countries. The growing burden of chronic pain disorders, arthritis, sports injuries, and orthopedic conditions is accelerating the adoption of topical and transdermal pain relief solutions such as lidocaine, diclofenac, and capsaicin patches.

Browse the full report description of “Non-Opioid Pain Patches Market Size, Share & Trends Analysis Report, By Product Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Methyl Salicylate Patches, Ketoprofen Patches, Counterirritant Herbal Patches, Combination Drug Patches, Cannabidiol (CBD) Pain Patches, Others), By Patch Technology (Transdermal Drug Delivery Patches, Topical Hydrogel Patches, Matrix Patches, Reservoir Patches, Drug-in-Adhesive Patches, Microneedle Patches), By End User (Hospitals, Homecare Settings, Sports & Rehabilitation Centers, Ambulatory Surgical Centers, Pain Management Clinics), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/non-opioid-pain-patches-market-share

Among product categories, Lidocaine Patches are emerging as one of the fastest-growing segments due to increasing prescription use for neuropathic pain, post-herpetic neuralgia, and chronic musculoskeletal pain management. The segment is witnessing strong demand across hospitals, home care settings, and rehabilitation centers owing to improved patient compliance, localized drug delivery, and reduced gastrointestinal side effects compared to oral analgesics. The home care settings segment is also gaining traction due to increasing self-medication trends and rising adoption of OTC pain management products. Additionally, a growing elderly population and increasing incidence of osteoarthritis and chronic back pain are creating sustained long-term demand for non opioid pain patches globally. Advancements in drug-in-adhesive systems, hydrogel patches, and microneedle technologies are further supporting market innovation and commercialization activities.

Key Leaders Transforming the Non-Opioid Pain Patches Market

Key leaders transforming the non-opioid pain patches market are driving growth through expansion of OTC analgesic patch availability, wider adoption of lidocaine and diclofenac-based transdermal therapies, and increasing use in home care and sports rehabilitation settings. They are also accelerating innovation in drug-in-adhesive and hydrogel patch technologies to improve skin absorption and patient comfort, while expanding access through genericization and cost-effective formulations. At the same time, rising focus on neuropathic and musculoskeletal pain management is supporting broader clinical acceptance beyond hospitals into ambulatory and self-care environments.

• In July 2024, Scilex Holding Company announced a collaboration with ACEA Therapeutics to expand the commercialization of ZTlido®, a non-opioid lidocaine topical pain patch, across Greater China, including mainland China, Taiwan, Hong Kong, and Macau. The agreement aims to strengthen Scilex’s international presence in the non-opioid pain management market and improve patient access to innovative pain relief solutions.

• In September 2024, Haleon announced plans to increase its stake in Tianjin TSKF Pharmaceutical Co., Ltd. to 88% to strengthen its presence in China’s consumer healthcare and pain relief market. Through TSKF, Haleon markets major pain relief brands, including Voltaren, supporting the company’s expansion in non-opioid pain management solutions across China.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Patch Technology
  • By End-User
• Competitive Landscape – Hisamitsu Pharmaceutical, Scilex Holding Company, Teikoku Pharma USA (Teikoku Seiyaku), Endo International, and Sanofi, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Non Opioid Pain Patches Market Report Segment

By Product Type

• Lidocaine Patches
• Diclofenac Patches
• Capsaicin Patches
• Methyl Salicylate Patches
• Ketoprofen Patches
• Counterirritant Herbal Patches
• Combination Drug Patches
• Cannabidiol (CBD) Pain Patches
• Others

By Patch Technology

• Transdermal Drug Delivery Patches
• Topical Hydrogel Patches
• Matrix Patches
• Reservoir Patches
• Drug-in-Adhesive Patches
• Microneedle Patches

By End User

• Hospitals
• Homecare Settings
• Sports & Rehabilitation Centers
• Ambulatory Surgical Centers
• Pain Management Clinics

Global Non Opioid Pain Patches Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/non-opioid-pain-patches-market-share